Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2021 Filed Jun 24, 2021 21:00 UTC |
Steele Robin JoanDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001401914-21-000103 · wf-form4_162456842200952.xml · derivative · entry 1 Steele Robin Joan · CIK 0001301008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 24, 2021 Filed Jun 24, 2021 20:56 UTC |
Matz Gregory WDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001401914-21-000101 · wf-form4_162456818462982.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 24, 2021 Filed Jun 24, 2021 20:43 UTC |
Blanchard Cheryl RDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001401914-21-000094 · wf-form4_162456741352719.xml · derivative · entry 1 Blanchard Cheryl R · CIK 0001326530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 24, 2021 Filed Jun 24, 2021 20:51 UTC |
Kelley Susan L.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001401914-21-000098 · wf-form4_162456781006637.xml · derivative · entry 1 Kelley Susan L. · CIK 0001519612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 24, 2021 Filed Jun 24, 2021 20:35 UTC |
RASTETTER WILLIAM HDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001401914-21-000090 · wf-form4_162456686646072.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 24, 2021 Filed Jun 24, 2021 20:40 UTC |
Grossman Jessica D.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001401914-21-000092 · wf-form4_162456719866945.xml · derivative · entry 1 Grossman Jessica D. · CIK 0001736781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 20:05 UTC |
Ononye-Onyia Sophia NnennaDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001401914-21-000068 · wf-form4_161894910752094.xml · derivative · entry 1 Ononye-Onyia Sophia Nnenna · CIK 0001857183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common stock · 45,000 shares Expires 2031-04-16 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:17 UTC |
Fair John AChief Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 168,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001739140-21-000002 · wf-form4_161186864677254.xml · derivative · entry 1 Fair John A · CIK 0001739140 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,000 Underlying: Common stock · 168,000 shares Expires 2031-01-26 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:05 UTC |
JOHNSON SABRINA MARTUCCIDirector · Chef Executive Officer
|
GrantStock Option (right to buy) · Derivative | 525,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001199102-21-000005 · wf-form4_161186790314013.xml · derivative · entry 1 JOHNSON SABRINA MARTUCCI · CIK 0001199102 · Director · Chef Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,000 Underlying: Common stock · 525,000 shares Expires 2031-01-26 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:13 UTC |
Walters-Hoffert LisaChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 168,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001711576-21-000002 · wf-form4_161186841012861.xml · derivative · entry 1 Walters-Hoffert Lisa · CIK 0001711576 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,000 Underlying: Common stock · 168,000 shares Expires 2031-01-26 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| June 25, 2020 Filed Jun 27, 2020 00:57 UTC |
Matz Gregory WDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000098 · wf-form4_159321940289407.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2030-06-25 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 25, 2020 Filed Jun 27, 2020 00:56 UTC |
Blanchard Cheryl RDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000097 · wf-form4_159321937668046.xml · derivative · entry 1 Blanchard Cheryl R · CIK 0001326530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2030-06-25 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 25, 2020 Filed Jun 27, 2020 00:56 UTC |
RASTETTER WILLIAM HDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000096 · wf-form4_159321935213925.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2030-06-25 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 25, 2020 Filed Jun 27, 2020 00:55 UTC |
Steele Robin JoanDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000095 · wf-form4_159321932732948.xml · derivative · entry 1 Steele Robin Joan · CIK 0001301008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2030-06-25 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 25, 2020 Filed Jun 27, 2020 00:55 UTC |
Grossman Jessica D.Director
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000094 · wf-form4_159321930436873.xml · derivative · entry 1 Grossman Jessica D. · CIK 0001736781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2030-06-25 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 25, 2020 Filed Jun 27, 2020 00:55 UTC |
Kelley Susan L.Director
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000093 · wf-form4_159321928214573.xml · derivative · entry 1 Kelley Susan L. · CIK 0001519612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2030-06-25 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 21:47 UTC |
Fair John AChief Strategy Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000036 · wf-form4_158379045238597.xml · derivative · entry 1 Fair John A · CIK 0001739140 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 Underlying: Common stock · 68,000 shares Expires 2030-03-06 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 21:43 UTC |
JOHNSON SABRINA MARTUCCIDirector · Chef Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 280,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000034 · wf-form4_158379021939186.xml · derivative · entry 1 JOHNSON SABRINA MARTUCCI · CIK 0001199102 · Director · Chef Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common stock · 280,000 shares Expires 2030-03-06 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 21:42 UTC |
Walters-Hoffert LisaChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000032 · wf-form4_158379012050278.xml · derivative · entry 1 Walters-Hoffert Lisa · CIK 0001711576 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 Underlying: Common stock · 68,000 shares Expires 2030-03-06 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 00:55 UTC |
Blanchard Cheryl RDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $0.79 | $0.00 |
DisclosureSEC source: 0001401914-19-000100 · wf-form4_157438410017998.xml · derivative · entry 1 Blanchard Cheryl R · CIK 0001326530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common stock · 45,000 shares Expires 2029-11-20 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 11:08 UTC |
Grossman Jessica D.Director
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001736781-19-000001 · wf-form4_156051051083771.xml · derivative · entry 1 Grossman Jessica D. · CIK 0001736781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 18:35 UTC |
Kelley Susan L.Director
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001401914-19-000066 · wf-form4_156053729327372.xml · derivative · entry 1 Kelley Susan L. · CIK 0001519612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 18:33 UTC |
RASTETTER WILLIAM HDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001401914-19-000064 · wf-form4_156053719512628.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 18:31 UTC |
Steele Robin JoanDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001401914-19-000062 · wf-form4_156053704682456.xml · derivative · entry 1 Steele Robin Joan · CIK 0001301008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 11:04 UTC |
Matz Gregory WDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001536574-19-000001 · wf-form4_156051028016144.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 11:01 UTC |
HAWLEY ROGERDirector
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001257386-19-000007 · wf-form4_156051008272911.xml · derivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| April 11, 2019 Filed Apr 15, 2019 20:25 UTC |
HAWLEY ROGERDirector
|
PurchaseCommon stock | 454,545 | $1.10 | $499,999.50 |
DisclosureSEC source: 0001257386-19-000005 · wf-form4_155535993775373.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 944,956 F1 · security: The reported securities were purchased by the reporting person in the underwritten public offering of the issuer which closed on April 11, 2019. The reported securities are held in The Hawley Family Trust Dated October 22, 2004, of which the reporting person is the trustee. Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 22:30 UTC |
Walters-Hoffert LisaChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001209191-19-006217 · doc4.xml · derivative · entry 1 Walters-Hoffert Lisa · CIK 0001711576 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-01-29 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 22:30 UTC |
JOHNSON SABRINA MARTUCCIDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 195,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001209191-19-006215 · doc4.xml · derivative · entry 1 JOHNSON SABRINA MARTUCCI · CIK 0001199102 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Stock · 195,000 shares Expires 2029-01-29 F1 · derivative.exercise_date: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 21:45 UTC |
Matz Gregory WDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001209191-18-051267 · doc4.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-09-13 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 22:23 UTC |
Walters-Hoffert LisaChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001209191-18-050351 · doc4.xml · derivative · entry 1 Walters-Hoffert Lisa · CIK 0001711576 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-09-07 F1 · derivative.exercise_date: This stock options vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 22:22 UTC |
JOHNSON SABRINA MARTUCCIDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 192,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001209191-18-050350 · doc4.xml · derivative · entry 1 JOHNSON SABRINA MARTUCCI · CIK 0001199102 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,000 Underlying: Common Stock · 192,000 shares Expires 2028-09-07 F1 · derivative.exercise_date: This stock options vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 21:52 UTC |
HAWLEY ROGERDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-18-042387 · doc4.xml · derivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-07-10 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 21:46 UTC |
Steele Robin JoanDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-18-042386 · doc4.xml · derivative · entry 1 Steele Robin Joan · CIK 0001301008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-07-10 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 21:44 UTC |
Kelley Susan L.Director
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-18-042384 · doc4.xml · derivative · entry 1 Kelley Susan L. · CIK 0001519612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-07-10 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 21:45 UTC |
RASTETTER WILLIAM HDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-18-042385 · doc4.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-07-10 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 21:42 UTC |
Grossman Jessica D.Director
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-18-042381 · doc4.xml · derivative · entry 1 Grossman Jessica D. · CIK 0001736781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-07-10 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 22:30 UTC |
HAWLEY ROGERDirector
|
PurchaseCommon stock | 140,000 | $1.45 | $203,378.00 |
DisclosureSEC source: 0001209191-18-037306 · doc4.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 F1 · price: The price reported is a weighted average. This transaction was executed in multiple trades at prices ranging from $1.385 to $1.48. The reporting person undertakes to provide full information regarding the number of shares and prices at which the trades were effected upon request to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 21:21 UTC |
Kelley Susan L.Director
|
GrantOption to Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-17-046001 · doc4.xml · derivative · entry 1 Kelley Susan L. · CIK 0001519612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-07-19 F1 · derivative.exercise_price: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. F2 · shares: Dr. Kelley was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan. F3 · derivative.exercise_date: The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Dr. Kelley's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 21:12 UTC |
Walters-Hoffert LisaChief Financial Officer
|
GrantCommon Stock | 443,512 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-045994 · doc4.xml · nonDerivative · entry 1 Walters-Hoffert Lisa · CIK 0001711576 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By The Lisa Walters-Hoffert Survivor's Trust dated October 31, 2002 Disclosed balance after: 443,512 F1 · price: In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the "Corporation"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. ("Dare Operations") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the "Transaction"). F2 · price: The shares reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares were received in connection with the Transaction in exchange for 2,184,823 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis). Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 21:15 UTC |
RASTETTER WILLIAM HDirector
|
GrantOption to Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-17-045998 · doc4.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-07-19 F1 · derivative.exercise_price: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. F2 · shares: Dr. Rastetter was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan. F3 · derivative.exercise_date: The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Dr. Rastetter's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 21:03 UTC |
Steele Robin JoanDirector
|
GrantOption to Purchase Common Stock · Derivative | 2,200 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-17-045984 · doc4.xml · derivative · entry 2 Steele Robin Joan · CIK 0001301008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Underlying: Common Stock · 2,200 shares Expires 2027-07-19 F3 · derivative.exercise_price: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. F4 · shares: Ms. Steele was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan and the Non-Employee Director Compensation Policy. F5 · derivative.exercise_date: The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Ms. Steele's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 21:03 UTC |
Steele Robin JoanDirector
|
GrantCommon Stock | 246,171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-045984 · doc4.xml · nonDerivative · entry 1 Steele Robin Joan · CIK 0001301008 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Robin J. Steele Trust DTD 1/30/2015 Disclosed balance after: 246,171 F1 · price: In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the "Corporation"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. ("Dare Operations") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the "Transaction"). F2 · price: The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 1,212,685 shares of Dare Operations. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis). Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:09 UTC |
HAWLEY ROGERDirector
|
GrantOption to Purchase Common Stock · Derivative | 2,200 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-17-045934 · doc4.xml · derivative · entry 4 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Underlying: Common Stock · 2,200 shares Expires 2027-07-19 F6 · derivative.exercise_price: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. F7 · shares: Mr. Hawley was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan and the Non-Employee Director Compensation Policy. F8 · derivative.exercise_date: The Director Options will vest in equal annual installments over a three year period measured from the date of grant, subject to Mr. Hawley's continued service to the Corporation, and will become exercisable in full upon a change of control of the Corporation. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:09 UTC |
HAWLEY ROGERDirector
|
GrantOption to Purchase Common Stock · Derivative | 10,149 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0001209191-17-045934 · doc4.xml · derivative · entry 3 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,149 Underlying: Common Stock · 10,149 shares Expires 2025-12-01 F1 · shares: In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the "Corporation"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. ("Dare Operations") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the "Transaction"). F4 · shares: The shares of common stock of the Corporation excercisable pursuant to the option reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These options to purchase common stock of the Corporation were received in connection with the Transaction in exchange for 50,000 options to purchase shares of common stock of Dare Operations. Each option to purchase one share of common stock of Dare Operations was cancelled and exchanged for the right to receive an option to purchase 0.2029969047 shares of common stock of the Corporation (on a post-split basis). F4 · price: The shares of common stock of the Corporation excercisable pursuant to the option reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These options to purchase common stock of the Corporation were received in connection with the Transaction in exchange for 50,000 options to purchase shares of common stock of Dare Operations. Each option to purchase one share of common stock of Dare Operations was cancelled and exchanged for the right to receive an option to purchase 0.2029969047 shares of common stock of the Corporation (on a post-split basis). F5 · derivative.exercise_date: Commencing on May 28, 2015 (the "Vesting Start Date"), Mr. Hawley shall acquire a vested interest in the shares of common stock of the Corporation exercisable pursuant to the option in a series of three (3) successive annual installments on the yearly anniversary of the Vesting Start Date, subject to Mr. Hawley's continued service to the Corporation. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:09 UTC |
HAWLEY ROGERDirector
|
GrantCommon Stock | 307,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-045934 · doc4.xml · nonDerivative · entry 2 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Hawley Family Trust Dated October 22, 2004 Disclosed balance after: 490,411 F1 · price: In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the "Corporation"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. ("Dare Operations") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the "Transaction"). F3 · price: The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 1,515,857 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis). Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:09 UTC |
HAWLEY ROGERDirector
|
GrantCommon Stock | 182,697 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-045934 · doc4.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,697 F1 · price: In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the "Corporation"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. ("Dare Operations") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the "Transaction"). F2 · price: The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 900,000 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis). Read SEC document |
| July 19, 2017 Filed Jul 25, 2017 20:20 UTC |
JOHNSON SABRINA MARTUCCIDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 962,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-046159 · doc4.xml · nonDerivative · entry 1 JOHNSON SABRINA MARTUCCI · CIK 0001199102 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By The Vincent S. Johnson and Sabrina M. Johnson Family Trust Dated February 4, 2005 Disclosed balance after: 962,062 F1 · price: In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the "Corporation"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. ("Dare Operations") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the "Transaction"). F2 · price: The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 4,739,295 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis). Read SEC document |
| July 19, 2017 Filed Dec 8, 2017 21:08 UTC Amendment |
RASTETTER WILLIAM HDirector
|
GrantOption to Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-17-064688 · doc4a.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-07-19 F1 · derivative.exercise_price: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. F2 · shares: Dr. Rastetter was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan. F3 · derivative.exercise_date: This form amends a Form 4 previously filed for Dr. Rastetter on July 21, 2017, to correct the description of the vesting schedule of the stock options. F4 · derivative.exercise_date: The Director Options will vest in full on the earlier of the one year anniversary of the date of grant or immediately prior to the Corporation's 2018 annual meeting of stockholders. Read SEC document |
| July 19, 2017 Filed Dec 8, 2017 21:07 UTC Amendment |
Kelley Susan L.Director
|
GrantOption to Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $6.56 | $0.00 |
DisclosureSEC source: 0001209191-17-064686 · doc4a.xml · derivative · entry 1 Kelley Susan L. · CIK 0001519612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-07-19 F1 · derivative.exercise_price: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. F2 · shares: Dr. Kelley was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan. F3 · derivative.exercise_date: The Director Options will vest in full on the earlier of the one year anniversary of the date of grant or immediately prior to the Corporation's 2018 annual meeting of stockholders. F4 · derivative.exercise_date: This form amends a Form 4 previously filed for Dr. Kelley on July 21, 2017, to correct the description of the vesting schedule of the stock options. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.